Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBiodexa Pharmaceuticals Plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Biodexa Pharmaceuticals Plc Earnings Date And Information
Biodexa Pharmaceuticals Plc last posted its earnings results on Thursday, September 26th, 2024. The company reported $-10.08291 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02235 by $10.06056. The company had revenue of 0 for the quarter and had revenue of 381,000 for the year. Biodexa Pharmaceuticals Plc has generated $-224 earnings per share over the last year ($-224.13 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Biodexa Pharmaceuticals Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 25th, 2025 based on prior year's report dates.
Biodexa Pharmaceuticals Plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2024 | Q2 2024 | N/A | -$10.08 | N/A | $13,430 | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$65.94 | N/A | N/A | $83,000 |
| 06/29/2023 | Q2 2023 | N/A | -$14.38 | N/A | N/A | $298,000 |
| 12/30/2022 | Q4 2022 | N/A | -$370.62 | N/A | N/A | $231,000 |
| 06/29/2022 | Q2 2022 | N/A | -$248.66 | N/A | N/A | $468,000 |
| 12/30/2021 | Q4 2021 | N/A | -$188.64 | N/A | N/A | $177,000 |
| 06/29/2021 | Q2 2021 | N/A | $0.00 | N/A | N/A | $401,000 |
| 12/30/2020 | Q4 2020 | N/A | $0.00 | N/A | N/A | $175,000 |
| 06/29/2020 | Q2 2020 | N/A | $0.00 | N/A | N/A | $168,000 |
| 06/29/2019 | Q2 2019 | N/A | $0.00 | N/A | N/A | $452,000 |
| 06/29/2018 | Q2 2018 | N/A | $0.00 | N/A | N/A | $549,000 |
| 12/30/2017 | Q4 2017 | N/A | $0.00 | N/A | N/A | $516,000 |
| 06/29/2017 | Q2 2017 | N/A | $0.00 | N/A | N/A | $473,000 |
| 12/30/2016 | Q4 2016 | N/A | $0.00 | N/A | N/A | $-3,614,000 |
| 06/29/2016 | Q2 2016 | N/A | $0.00 | N/A | N/A | $2.95 M |
| 12/30/2015 | Q4 2015 | N/A | $0.00 | N/A | N/A | $1.05 M |
| 06/29/2015 | Q2 2015 | N/A | $0.00 | N/A | N/A | $324,000 |
| 12/30/2014 | Q4 2014 | N/A | $0.00 | N/A | N/A | $121,000 |
| 06/29/2014 | Q2 2014 | N/A | $0.00 | N/A | N/A | $36,000 |
| 12/30/2013 | Q4 2013 | N/A | $0.00 | N/A | N/A | $131,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biodexa Pharmaceuticals Plc Earnings: FAQ's
Biodexa Pharmaceuticals Plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 25th, 2025 based offlast year's report dates.
The conference call for Biodexa Pharmaceuticals Plc's latest earnings report can be listened to online.
The conference call transcript for Biodexa Pharmaceuticals Plc's latest earnings report can be read online.
Biodexa Pharmaceuticals Plc (:BDRX) has a recorded annual revenue of $381,000.
Biodexa Pharmaceuticals Plc (:BDRX) has a recorded net income of $-7,079,000.Biodexa Pharmaceuticals Plc has generated $-224.13 earnings per share over the last four quarters.
Biodexa Pharmaceuticals Plc (:BDRX) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.